VaramirStart free · no cardSign in
GILD as of Oct 30 · 20:32 ET
GILDNasdaqBiological Products, (No Diagnostic Substances)

Gilead Sciences, Inc. · Brief

Next report

101 days

Feb 9 · after closeest.Q4 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±4.4%
avg realized
±4.1%
Feb 11 '25±4.1%▲+7.46%×1.84
Apr 24 '25±3.8%▼−2.81%×0.75
Aug 7 '25±4.9%▲+8.28%×1.69
Q3 FY25±5.8%▲+1.14%×0.20
Feb 10 '26±4.6%▲+5.82%×1.26
Q1 FY26±4.0%▼−2.04%×0.51
Q2 FY26±4.6%▼−2.58%×0.57
Q3 FY26±3.4%▲+3.06%×0.89
quarterimplied−10%0+10%realized×
Q3 FY26±3.4%▲+3.06%×0.89
Q2 FY26±4.6%▼−2.58%×0.57
Q1 FY26±4.0%▼−2.04%×0.51
Feb '26±4.6%▲+5.82%×1.26
Q3 FY25±5.8%▲+1.14%×0.20
Aug '25±4.9%▲+8.28%×1.69
2 older reports
Apr '25±3.8%▼−2.81%×0.75
Feb '25±4.1%▲+7.46%×1.84
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 9 report · est.

—

Linked exposure

GILD report session

Customers 1

MCKMcKesson×0.27
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 15report dateEarnings date confirmed: Oct 29, after close.Source
Oct 15impliedImplied move: ±5.5% into Oct 29 earnings (Oct 15 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.